In this work, we introduce Progressive Growing of Patch Size (PGPS), an automatic curriculum learning approach for 3D medical image segmentation. Curriculum learning structures the training process by presenting progressively more complex samples to the model, often improving training convergence. In our case, we operationalize this by starting training with small patch sizes and gradually increasing them, which naturally improves the foreground-to-background class voxel ratio in early training stages. We evaluate our approach in two distinct settings. First, a resource-efficient mode maintains a constant batch size throughout training to reduce the input tensor size and computational cost (FLOPs) relative to conventional training. Second, a performance mode inversely scales the batch size relative to the patch volume, keeping the total FLOPs comparable to standard training while maximizing final segmentation quality. Both modes are evaluated on segmentation performance (Dice score) and computational costs across 15 diverse and popular 3D medical image segmentation tasks. The resource-efficient mode matches the segmentation performance of the conventional constant patch size baseline while reducing wall-clock training time to only 44%. We show that the performance mode improves upon the constant patch size baseline, achieving a statistically significant relative gain in mean Dice score of 1.28%. Remarkably, the performance mode surpasses the constant patch size baseline across all 15 tasks, while simultaneously reducing wall-clock training time to only 89%. We found that the benefits are particularly pronounced for tasks with severe foreground-to-background voxel imbalance, such as lesion segmentation. As a consequence of the improved convergence, the proposed performance mode reduces segmentation performance variance relative to conventional constant patch size training, making model comparisons less sensitive to training stochasticity. Finally, our experiments demonstrate that PGPS is not tied to a specific architecture but represents a broadly applicable strategy that consistently boosts performance across diverse segmentation models, including UNet, UNETR, and SwinUNETR. In summary, this simple yet effective transformation of the input sampling strategy substantially improves both segmentation performance and training efficiency, while remaining compatible with diverse segmentation backbones.

Recent advancements in artificial intelligence (AI) and the vast data generated by modern clinical systems have driven the development of AI solutions in medical imaging, encompassing image reconstruction, segmentation, diagnosis, and treatment planning. Despite these successes and potential, many stakeholders worry about the risks and ethical implications of imaging AI, viewing it as complex, opaque, and challenging to understand, use, and trust in critical clinical applications. The FUTURE-AI guideline for trustworthy AI in healthcare was established based on six guiding principles: Fairness, Universality, Traceability, Usability, Robustness, and Explainability. Through international consensus, a set of recommendations was defined, covering the entire lifecycle of medical AI tools, from design, development, and validation to regulation, deployment, and monitoring. In this paper, we describe how these specific recommendations can be instantiated in the domain of medical imaging, providing an overview of current best practices along with guidelines and concrete metrics on how those recommendations could be met, offering a valuable resource to the international medical imaging community.

Despite technological and medical advances, the detection, interpretation, and treatment of cancer based on imaging data continue to pose significant challenges. These include inter-observer variability, class imbalance, dataset shifts, inter- and intra-tumour heterogeneity, malignancy determination, and treatment effect uncertainty. Given the recent advancements in image synthesis, Generative Adversarial Networks (GANs), and adversarial training, we assess the potential of these technologies to address a number of key challenges of cancer imaging. We categorise these challenges into (a) data scarcity and imbalance, (b) data access and privacy, (c) data annotation and segmentation, (d) cancer detection and diagnosis, and (e) tumour profiling, treatment planning and monitoring. Based on our analysis of 164 publications that apply adversarial training techniques in the context of cancer imaging, we highlight multiple underexplored solutions with research potential. We further contribute the Synthesis Study Trustworthiness Test (SynTRUST), a meta-analysis framework for assessing the validation rigour of medical image synthesis studies. SynTRUST is based on 26 concrete measures of thoroughness, reproducibility, usefulness, scalability, and tenability. Based on SynTRUST, we analyse 16 of the most promising cancer imaging challenge solutions and observe a high validation rigour in general, but also several desirable improvements. With this work, we strive to bridge the gap between the needs of the clinical cancer imaging community and the current and prospective research on data synthesis and adversarial networks in the artificial intelligence community.